Sleep Disorders Trial, Recruiting NCT07319117 Sponsor: Leeds Beckett University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07319117
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing and able to sign a consent form written in English
  • You are between 40 and 60 years old
  • You are female
  • You drink caffeine every day
  • You are generally healthy and do not have any significant physical or mental health conditions

Who may not be able to join:

  • You currently smoke cigarettes or use a vaping device
  • You have a known allergy or intolerance to any of the food or drink products used in the trial
  • You are not willing to drink coffee as part of the trial
  • You have been diagnosed with a psychiatric or mental health condition
  • You use recreational drugs
  • You have been diagnosed with a heart or circulatory condition, such as heart disease or high blood pressure
  • You are currently taking any prescribed medication, except for contraceptives or hormone replacement therapy (HRT)
  • You have Raynaud's disease or any other condition affecting your circulation
  • You have had an injury or infection in your hand or arm within the last month
  • You have a chronic pain condition, or you experience severe numbness or pain when exposed to cold temperatures
  • You have previously had a brain injury or brain surgery
  • You work night shifts
  • You are currently pregnant or breastfeeding
  • You have previously taken part in a laboratory-based stress study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zoe K Kolokotroni, PhD, Leeds Beckett University

Phone: +441138123271

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Leeds Beckett University
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
1 August 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Working Memory Performance; Cognitive flexibility and attentional set-shifting.; Sustained attention.; Inhibitory control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov